Get the Stockscreener App
87.58
1.68%
1.45
After Hours:
87.58
Overview
News
Price History
Option Chain
Financials
Why MET Down?
Discussions
Forecast
Dividend History
Metlife Inc stock is traded at $87.58, with a volume of 4.22M.
It is up +1.68% in the last 24 hours and up +12.31% over the past month.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
See More
Previous Close:
$86.13
Open:
$86.72
24h Volume:
4.22M
Relative Volume:
1.20
Market Cap:
$56.35B
Revenue:
$77.59B
Net Income/Loss:
$3.62B
P/E Ratio:
16.94
EPS:
5.1701
Net Cash Flow:
$16.53B
1W Performance:
+4.94%
1M Performance:
+12.31%
6M Performance:
+6.48%
1Y Performance:
+10.99%
1-Day Range:
$86.43
$87.96
1-Week Range:
$83.22
$87.96
52-Week Range:
$67.33
$87.96
Metlife Inc Stock (MET) Company Profile
Name
Metlife Inc
Sector
Industry
Phone
212-578-5500
Address
200 PARK AVENUE, NEW YORK, NY
Compare MET vs MFC, AFL, PRU, PUK
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MET
Metlife Inc
|
87.58 | 55.42B | 77.59B | 3.62B | 16.53B | 5.1701 |
MFC
Manulife Financial Corp
|
39.79 | 65.38B | 44.31B | 4.69B | 20.94B | 2.5185 |
AFL
Aflac Inc
|
116.45 | 59.61B | 18.11B | 4.64B | 2.93B | 8.812 |
PRU
Prudential Financial Inc
|
106.51 | 36.53B | 62.83B | 3.60B | 9.79B | 9.7297 |
PUK
Prudential Plc Adr
|
26.04 | 31.27B | 27.81B | 4.12B | 1.87B | 3.07 |
Metlife Inc Stock (MET) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-16-25 | Initiated | Mizuho | Outperform |
| Sep-19-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-16-25 | Initiated | Wolfe Research | Outperform |
| Jan-23-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-09-24 | Initiated | TD Cowen | Buy |
| Sep-05-24 | Initiated | Barclays | Overweight |
| Jan-08-24 | Upgrade | Goldman | Neutral → Buy |
| Nov-17-23 | Resumed | Barclays | Overweight |
| Oct-05-23 | Initiated | Deutsche Bank | Hold |
| Sep-14-23 | Upgrade | Jefferies | Hold → Buy |
| Jan-09-23 | Downgrade | Goldman | Buy → Neutral |
| Dec-09-22 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-22 | Initiated | Raymond James | Mkt Perform |
| Jun-23-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-24-22 | Initiated | Citigroup | Buy |
| Jan-26-22 | Initiated | Jefferies | Buy |
| Jan-21-22 | Initiated | Wolfe Research | Peer Perform |
| Jan-12-22 | Reiterated | UBS | Buy |
| Jan-05-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-03-21 | Initiated | Goldman | Buy |
| Apr-21-21 | Initiated | UBS | Buy |
| Jan-06-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-17-20 | Initiated | Barclays | Overweight |
| Jun-01-20 | Resumed | BofA/Merrill | Buy |
| Mar-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Jan-07-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-16-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-19-19 | Downgrade | Sandler O'Neill | Buy → Hold |
| Jan-16-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jan-02-19 | Upgrade | Sandler O'Neill | Hold → Buy |
| Jun-04-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-25-18 | Initiated | Credit Suisse | Outperform |
| Mar-26-18 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jan-02-18 | Initiated | Deutsche Bank | Hold |
| Nov-10-17 | Downgrade | Sandler O'Neill | Buy → Hold |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| May-25-17 | Upgrade | FBR & Co. | Mkt Perform → Outperform |
| Mar-06-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jan-26-17 | Initiated | Citigroup | Sell |
| Dec-09-16 | Downgrade | Standpoint Research | Buy → Hold |
View All
Metlife Inc Stock (MET) Latest News
MetLife Inc. stock rises Thursday, still underperforms market - MarketWatch
MetLife (MET) director McKenzie credited 169 shares via deferred dividend reinvestment - Stock Titan
[Form 4] METLIFE INC Insider Trading Activity - Stock Titan
MetLife (NYSE: MET) director adds 39 deferred shares via dividends - Stock Titan
MetLife (MET) director Jeh C. Johnson acquires 61 shares through deferred dividend reinvestment - Stock Titan
MetLife (MET) director granted 42 shares via dividend reinvestment - Stock Titan
MetLife (MET) director adds 20 shares via deferred dividend reinvestment - Stock Titan
MetLife (NYSE: MET) director gains 7 shares via deferred compensation plan - Stock Titan
MetLife (NYSE: MET) director gains 678 shares via deferred stock plan - Stock Titan
MetLife (MET) U.S. Business president awarded 127 shares via deferred plan - Stock Titan
AI's Inflationary Impact on Economy, Says MetLife's Drew Matus - GuruFocus
MetLife Broadens Settlement Solutions Portfolio With NQA-FA - Zacks Investment Research
MetLife (MET) Unveils Flexible Settlement Agreement for Non-Phys - GuruFocus
MetLife launches deferred payment product for injury settlements - Investing.com
The ’Duck Stock’ Keeps Quietly Making Money for Shareholders - Investing.com
MetLife launches deferred payment product for injury settlements By Investing.com - Investing.com Canada
MetLife Launches New Deferred Payment Option for Non-Physical Injury Claims - marketscreener.com
Is MetLife stock outperforming the S&P 500? - MSN
MetLife Inc at Morgan Stanley US Financials Conference Transcript - GuruFocus
Lincoln National vs. MetLife: Which Financial Stock Is a Better Buy in 2026? - The Globe and Mail
MetLife Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
MetLife Inc. stock (US59156R1086): shares hover near 52-week high after solid Q1 earnings - AD HOC NEWS
$23M Settlement Ends MetLife’s Mortality Table Case - planadviser
Q1 Earnings Roundup: MetLife (NYSE:MET) And The Rest Of The Life Insurance Segment - Yahoo Finance
Metlife stock hits 52-week high at 85.31 USD - Investing.com
Metlife stock hits 52-week high at 85.31 USD By Investing.com - Investing.com Canada
METLIFE INC (NYSE:MET) Shows Strong Breakout Setup with High Technical and Quality Scores - ChartMill
Argus Adjusts Price Target on MetLife to $93 From $90, Maintains Buy Rating - marketscreener.com
MetLife Settles Mortality Table ERISA Lawsuit for $23M - plansponsor
MKL Stock Declines 15.4% in YTD: What Should Investors Do Now? - TradingView
Mortality table settlements for married retirees continue with MetLife’s $23 million agreement - Pensions & Investments
MetLife: Not Exciting, But It Works - Seeking Alpha
These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy? - MarketBeat
Should I Buy MET (MetLife, Inc.) | AI Analysis, Technical & News Insights - Kavout
MetLife (MET) Valuation Check As New Annuity Cancellation Feature Reshapes Income Mix - Yahoo Finance
MetLife Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
MWZ.DE Technical Analysis | Trend, Signals & Chart Patterns | METLIFE INC (FRA:MWZ) - ChartMill
Is MetLife Stock Outperforming the S&P 500? - Yahoo Finance
MetLife Inc (MET) Shares Surge 3.1% -- What GF Score of 77 Tells Investors - GuruFocus
MetLife Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
MetLife earnings in focus as insurers navigate softer market - Investing.com
Goldman Sachs, Johnson & Johnson, MetLife Named Among Newsweek’s World’s Greenest Companies 2026 - Yahoo Finance
MET Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MetLife EVP & CRO Marlene Debel sells $1.74m in shares By Investing.com - Investing.com South Africa
MetLife EVP & CRO Marlene Debel sells $1.74m in shares - Investing.com Australia
MetLife Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
MetLife CFO to Speak at Morgan Stanley US Financials Conference - standard-journal.com
MetLife (NYSE: MET) risk chief sells 21,312 shares after option exercises - Stock Titan
MetLife To Boost Pensions In $23M Mortality Data Suit Deal - Law360
Here's Why Investors Should Stay Neutral on MetLife Stock for Now - Yahoo Finance
MetLife Strikes Class Deal Worth $23 Million Over Pension Math - news.bloombergtax.com
Metlife Inc Stock (MET) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.56%
1.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):